These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 15010149)

  • 1. Prophylactic factor replacement in hemophilia.
    Carcao MD; Aledort L
    Blood Rev; 2004 Jun; 18(2):101-13. PubMed ID: 15010149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prophylactic treatment with clotting factor to prevent joint damage in patients with severe haemophilia: costs versus benefits].
    Roosendaal G; Lafeber FP
    Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2606-8. PubMed ID: 18161260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current issues in prophylactic therapy for persons with hemophilia.
    Dunn AL; Abshire TC
    Acta Haematol; 2006; 115(3-4):162-71. PubMed ID: 16549891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on treatment regimens: prophylaxis versus on-demand therapy.
    Manco-Johnson MJ
    Semin Hematol; 2003 Jul; 40(3 Suppl 3):3-9. PubMed ID: 14690062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unresolved issues in prophylaxis.
    Brown SA; Aledort LM; Astermark J; Berntorp E; van den Berg M; Blanchette V; Donfield S; Gringeri A; Hilgartner M; Kulkarni R; Leissinger C; Negrier C; Nuss R; Petterson H; Petrini P; Poulios N; Schramm W;
    Haemophilia; 2002 Nov; 8(6):817-21. PubMed ID: 12410654
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term low-dose secondary prophylaxis for severe and moderate hemophilia children with arthropathy in China: a single-center observation study].
    Wu RH; Wu XY; Zhang NN; Zhao L; Zhang JS; Zhen YZ; Peng Y
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):632-4. PubMed ID: 23906463
    [No Abstract]   [Full Text] [Related]  

  • 7. Daily dosing prophylaxis for haemophilia: a randomized crossover pilot study evaluating feasibility and efficacy.
    Lindvall K; Astermark J; Björkman S; Ljung R; Carlsson KS; Persson S; Berntorp E
    Haemophilia; 2012 Nov; 18(6):855-9. PubMed ID: 22681244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orthopaedic evaluation in children with severe haemophilia A or B submitted to primary prophylaxis therapy in a coagulopathy treatment centre.
    De Podestá Haje D; Ono F; De Oliveira GB; Almeida J; De Paula JC; Batista Neto LV; Silva Barros SB
    Haemophilia; 2011 Mar; 17(2):228-32. PubMed ID: 21070500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.
    Nilsson IM; Berntorp E; Löfqvist T; Pettersson H
    J Intern Med; 1992 Jul; 232(1):25-32. PubMed ID: 1640190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis for hemophilia: state of the art or state of confusion?
    Gruppo RA
    J Pediatr; 1998 Jun; 132(6):915-7. PubMed ID: 9627577
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemophilia prophylaxis in young patients--a long-term follow-up.
    Löfqvist T; Nilsson IM; Berntorp E; Pettersson H
    J Intern Med; 1997 May; 241(5):395-400. PubMed ID: 9183307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant clotting factors in the treatment of hemophilia.
    Lee C
    Thromb Haemost; 1999 Aug; 82(2):516-24. PubMed ID: 10605745
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of joint damage in hemophilic children with early prophylaxis].
    Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B
    Orthopade; 1999 Apr; 28(4):341-6. PubMed ID: 10335528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis for severe haemophilia: clinical and economical issues.
    Fischer K; Van Den Berg M
    Haemophilia; 2003 Jul; 9(4):376-81. PubMed ID: 12828671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of factor VIII and IX inhibitors among Saudi patients with hemophilia: Results from the Saudi national hemophilia screening program.
    Owaidah T; Momen AA; Alzahrani H; Almusa A; Alkasim F; Tarawah A; Nouno RA; Batniji FA; Alothman F; Alomari A; Abu-Herbish S; Abu-Riash M; Siddiqui K; Ahmed M; Mohamed SY; Saleh M
    Medicine (Baltimore); 2017 Jan; 96(2):e5456. PubMed ID: 28079788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemophilia and prophylaxis.
    Ljung R
    Pediatr Blood Cancer; 2013; 60 Suppl 1():S23-6. PubMed ID: 23109472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current status of prophylactic replacement therapy in children and adults with haemophilia.
    Ljung R; Gretenkort Andersson N
    Br J Haematol; 2015 Jun; 169(6):777-86. PubMed ID: 25819695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of hemophilia patients with inhibitors.
    Nilsson IM
    Transfus Med Rev; 1992 Oct; 6(4):285-93. PubMed ID: 1421831
    [No Abstract]   [Full Text] [Related]  

  • 19. Secondary prophylaxis in adolescent and adult haemophiliacs.
    Tagliaferri A; Di Perna C; Rivolta GF
    Blood Transfus; 2008 Sep; 6 Suppl 2(Suppl 2):s17-20. PubMed ID: 19105505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic infusion regimens in the management of hemophilia.
    Ljung RC
    Thromb Haemost; 1999 Aug; 82(2):525-30. PubMed ID: 10605746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.